No Data
No Data
H.C. Wainwright Maintains TScan Therapeutics(TCRX.US) With Buy Rating, Maintains Target Price $15
TScan Therapeutics Price Target Maintained With a $15.00/Share by HC Wainwright & Co.
BTIG Maintains TScan Therapeutics(TCRX.US) With Buy Rating, Maintains Target Price $12
A Quick Look at Today's Ratings for TScan Therapeutics(TCRX.US), With a Forecast Between $11 to $14
Analysts Offer Insights on Healthcare Companies: TScan Therapeutics (TCRX), Legend Biotech (LEGN) and ICU Medical (ICUI)
Express News | Needham Reiterates Buy on TScan Therapeutics, Maintains $11 Price Target
No Data
No Data